IndieBio

Type

Accelerator/Incubator

Status

Active

Location

San Francisco, United States

Total investments

550

Average round size

2M

Portfolio companies

248

Rounds per year

55.00

Lead investments

7

Follow on index

0.53

Exits

2

Stages of investment
Seed
Areas of investment
BiotechnologyFood and BeverageFood ProcessingHealth CareHealth DiagnosticsManufacturingMedicalLife ScienceSustainabilityAgriculture

Summary

IndieBio appeared to be the VC, which was created in 2014. The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the IndieBio, startups are often financed by SOSV, Velocity, Enterprise Ireland. The meaningful sponsors for the fund in investment in the same round are True Ventures, Supernode Ventures, Starlight Ventures. In the next rounds fund is usually obtained by SOSV, True Ventures, New Crop Capital.

The current fund was established by Arvind Gupta, Bill Liao.

Deals in the range of 1 - 5 millions dollars are the general things for fund. The higher amount of exits for fund were in 2019. The fund is generally included in 25-48 deals every year. Comparing to the other companies, this IndieBio performs on 28 percentage points less the average number of lead investments. The typical startup value when the investment from IndieBio is 1-5 millions dollars. The important activity for fund was in 2019. Considering the real fund results, this VC is 19 percentage points less often commits exit comparing to other organizations.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Girihlet, Sun Genomics, BeeFlow. Among the most successful fund investment fields, there are Food and Beverage, Biotechnology. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Show more

Investor highlights

Industry focus
Deep TechClimate techHealthcare
Stage focus
Series BSeries APre-SeedSeed
Geo focus
Generalist
Check size
250K — 525K

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
550
Lead investments
7
Exits
2
Rounds per year
55.00
Follow on index
0.53
Investments by industry
  • Biotechnology (361)
  • Health Care (170)
  • Medical (91)
  • Food and Beverage (84)
  • Life Science (79)
  • Show 125 more
Investments by region
  • United States (386)
  • Chile (6)
  • Argentina (21)
  • United Kingdom (28)
  • Israel (14)
  • Show 12 more
Peak activity year
2021
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
5
Avg. valuation at time of investment
9M
Group Appearance index
0.96
Avg. company exit year
12
Avg. multiplicator
16.13
Strategy success index
0.20

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Ingrediome 09 Feb 2024 Food and Beverage, Food Processing, Sustainability Seed HaMerkaz, Ness Ziona, Israel
Minus Materials 21 Sep 2022 Manufacturing, Building Material, Construction, Product Research Seed 275K United States, Boulder, Colorado
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.